ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NVLN Novelion Therapeutics Inc

0.68
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Novelion Therapeutics Inc NASDAQ:NVLN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.68 0.63 0.6677 0 01:00:00

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Auxilium Pharmaceuticals Inc. and Its Board of Directors In ...

30/06/2014 6:30pm

PR Newswire (US)


Novelion Therapeutics (NASDAQ:NVLN)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Novelion Therapeutics Charts.

NEW YORK, June 30, 2014 /PRNewswire/ -- Levi & Korsinsky is investigating the Board of Directors of Auxilium Pharmaceuticals Inc. ("Auxilium" or "the Company") (NasdaqGS: AUXL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to QLT Inc. (NasdaqGS: QLTI).

Protecting the Rights of Shareholders

Click here to learn more about the investigation: http://zlk.9nl.com/auxilium-pharmaceuticals-auxl, or call: 877-363-5972. There is no cost or obligation to you.

Under the terms of the transaction, Auxilium shareholders will receive 3.1359 shares of QLT Inc. for each share of Auxilium they own. The investigation concerns whether the Board of Auxilium breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether QLT Inc. is underpaying for Auxilium shares.

If you own Auxilium common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/auxilium-pharmaceuticals-auxl.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com

Logo - http://photos.prnewswire.com/prnh/20120409/MM84375LOGO

SOURCE Levi & Korsinsky, LLP

Copyright 2014 PR Newswire

1 Year Novelion Therapeutics Chart

1 Year Novelion Therapeutics Chart

1 Month Novelion Therapeutics Chart

1 Month Novelion Therapeutics Chart

Your Recent History

Delayed Upgrade Clock